Key facts
- This page summarizes Ajay Raju's Form 3 filing for Medicus Pharma Ltd. (MDCX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Dec 2024, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The shares are held of record by 215 Capital Togo PHL Fund I, LP ("215 Capital"). Togo PHL Management LLC (the "Management Company") has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein.